169 related articles for article (PubMed ID: 27404498)
1. Treatment of aplastic anaemia with lower-dose anti-thymocyte globulin produces similar response rates and survival as per standard dose anti-thymocyte globulin schedules.
Scott A; Morris K; Butler J; Mills AK; Kennedy GA
Intern Med J; 2016 Oct; 46(10):1198-1203. PubMed ID: 27404498
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of immunosuppressant therapy with lower dose of antithymocyte globulin and cyclosporine in aplastic anemia.
Malhotra P; Bodh V; Guru Murthy GS; Datta AK; Varma N; Varma S
Hematology; 2015 May; 20(4):239-44. PubMed ID: 25181305
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of combination therapy with anti-thymocyte globulin and cyclosporine A as a first-line treatment in adult patients with aplastic anemia: a comparison of rabbit and horse formulations.
Suzuki T; Kobayashi H; Kawasaki Y; Okazuka K; Hatano K; Fujiwara S; Oh I; Ohmine K; Kanda Y
Int J Hematol; 2016 Oct; 104(4):446-53. PubMed ID: 27338268
[TBL] [Abstract][Full Text] [Related]
4. Outcome of anti-thymocyte immunoglobulin plus cyclosporine A for severe aplastic anaemia with chronic hepatitis B virus infection.
Chen M; Zhuang J; Zhou D; Xu Y; Zhao Y; Wang S; Zhang W; Duan M; Zhu T; Li J; Cai H; Cao X; Han B
Ann Hematol; 2017 Apr; 96(4):581-587. PubMed ID: 28084534
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemia.
Afable MG; Shaik M; Sugimoto Y; Elson P; Clemente M; Makishima H; Sekeres MA; Lichtin A; Advani A; Kalaycio M; Tiu RV; O'Keefe CL; Maciejewski JP
Haematologica; 2011 Sep; 96(9):1269-75. PubMed ID: 21606164
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive therapy (IST) in adult patients with acquired aplastic anemia (AA): A single-center experience over the past 15 years.
Alashkar F; Oelmüller M; Herich-Terhürne D; Turki AT; Schmitz C; Vance C; Dührsen U; Röth A
Eur J Haematol; 2019 Jul; 103(1):18-25. PubMed ID: 30977158
[TBL] [Abstract][Full Text] [Related]
7. Rabbit antithymocyte globulin dose does not affect response or survival as first-line therapy for acquired aplastic anemia: a multicenter retrospective study.
Clé DV; Atta EH; Dias DSP; Lima CBL; Bonduel M; Sciuccati G; Medeiros LA; de Oliveira MM; Blum Fonseca PB; Saad STO; Hamerschlak N; Salvino MA; Garanito MP; Pazin-Filho A; Scheinberg P; Calado RT
Ann Hematol; 2018 Nov; 97(11):2039-2046. PubMed ID: 29978284
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study.
Shin SH; Yoon JH; Yahng SA; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Kim DW; Min WS; Park CW; Lee JW
Ann Hematol; 2013 Jun; 92(6):817-24. PubMed ID: 23318980
[TBL] [Abstract][Full Text] [Related]
9. Porcine antilymphocyte globulin (p-ALG) plus cyclosporine A (CsA) treatment in acquired severe aplastic anemia: a retrospective multicenter analysis.
Wei J; Huang Z; Guo J; Zhang Y; Wang C; Zhu X; Zhang Y
Ann Hematol; 2015 Jun; 94(6):955-62. PubMed ID: 25666078
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive therapy in patients with aplastic anemia: a single-center retrospective study.
Jalaeikhoo H; Khajeh-Mehrizi A
PLoS One; 2015; 10(5):e0126925. PubMed ID: 25970182
[TBL] [Abstract][Full Text] [Related]
11. Outcome of adult severe or very severe aplastic anemia treated with immunosuppressive therapy compared with bone marrow transplantation: multicenter trial.
Ahn MJ; Choi JH; Lee YY; Choi IY; Kim IS; Yoon SS; Park SY; Kim BK; Suh C; Son HJ; Jung CW; Lee JH; Sung JM; Im SA; Oh D; Jung SY; Yoon HJ; Cho KS; Lee JA; Yuh YJ; Kim SR; Ki M
Int J Hematol; 2003 Aug; 78(2):133-8. PubMed ID: 12953807
[TBL] [Abstract][Full Text] [Related]
12. Nationwide survey on the use of horse antithymocyte globulins (ATGAM) in patients with acquired aplastic anemia: A report on behalf of the French Reference Center for Aplastic Anemia.
Peffault de Latour R; Tabrizi R; Marcais A; Leblanc T; Lamy T; Mohty M; Tavitian S; Jubert C; Pasquet M; Galambrun C; Nguyen S; Cahn JY; Braun T; Deconinck E; Bay JO; Sicre de Fontbrune F; Barraco F; Socié G
Am J Hematol; 2018 May; 93(5):635-642. PubMed ID: 29377260
[TBL] [Abstract][Full Text] [Related]
13. A randomized comparison of cyclophosphamide vs. reduced dose cyclophosphamide plus fludarabine for allogeneic hematopoietic cell transplantation in patients with aplastic anemia and hypoplastic myelodysplastic syndrome.
Kim H; Lee JH; Joo YD; Bae SH; Hyun MS; Lee JH; Kim DY; Lee WS; Ryoo HM; Kim MK; Park JH; Lee KH;
Ann Hematol; 2012 Sep; 91(9):1459-69. PubMed ID: 22526363
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic efficacy evaluation of rabbit anti-thymocyte globulin combined with cyclosporine A in children with aplastic anemia].
Fu RT; Xue HM; Xu HG; Huang K; Fang JP; Huang SL; Chen C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):426-30. PubMed ID: 23628047
[TBL] [Abstract][Full Text] [Related]
15. [Results of immunosuppressive therapy in children with severe aplastic anaemia. Report by the Polish Paediatric Leukaemia and Lymphoma Study Group].
Pawelec K; Matysiak M; Niewiadomska E; Rokicka-Milewska R; Kowalczyk J; Stefaniak J; Balwierz W; Załecka-Czepko E; Chybicka A; Szmyd K; Sońta-Jakimczyk D; Bubała H; Krauze A; Wysocki M; Kurylak A; Wachowiak J; Kaczmarek-Kanold M; Stolarska M; Karolczyk I; Krawczuk-Rybak M; Leszczyńska E; Urasiński T; Peregud-Pogorzelski J; Balcerska A; Włazłowski M
Med Wieku Rozwoj; 2006; 10(3 Pt 1):832-9. PubMed ID: 17317914
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppressive therapy in adults with aplastic anaemia: single-institution experience from India.
Nair V; Sharma A; Das S; Sondhi V; Sharma S
Postgrad Med J; 2013 Sep; 89(1055):508-15. PubMed ID: 23686628
[TBL] [Abstract][Full Text] [Related]
17. Final results of the phase II study of rabbit anti-thymocyte globulin, ciclosporin, methylprednisone, and granulocyte colony-stimulating factor in patients with aplastic anaemia and myelodysplastic syndrome.
Kadia TM; Borthakur G; Garcia-Manero G; Faderl S; Jabbour E; Estrov Z; York S; Huang X; Pierce S; Brandt M; Koller C; Kantarjian HM; Ravandi F
Br J Haematol; 2012 May; 157(3):312-20. PubMed ID: 22360602
[TBL] [Abstract][Full Text] [Related]
18. Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults.
Zhu X; Guan J; Xu J; Wei J; Jiang L; Yin J; Zhao L; Zhang Y
Blood Cells Mol Dis; 2014 Sep; 53(3):157-60. PubMed ID: 24931461
[TBL] [Abstract][Full Text] [Related]
19. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
[TBL] [Abstract][Full Text] [Related]
20. Cadaveric kidney transplantation under prophylactic polyclonal antibody immunosuppression with anti-lymphoblast globulin versus anti-thymocyte globulin.
Indudhara R; Novick AC; Hodge E; Goormastic M; Papajcik D; Mastroianni B; Cook D
Urology; 1996 Jun; 47(6):807-12. PubMed ID: 8677568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
